Studies Point to a Growing Role for New Therapies and Immunotherapies in Treating Blood Cancers

Chemotherapy-free approaches could offer comparable efficacy with less toxicity Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with blood cancers, according to studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. https://mma.prnewswire.com/media/347783/American_Society_of_Hematology_logo.jpg “These

ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline

(NYSE:ARE), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations

ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline

ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline GlobeNewswire December 07, 2025 NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate

MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline

(NASDAQ:MLTX), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain

SNPS INVESTOR LOSSES: Lose Money on Synopsys, Inc.? Contact BFA Law before December 30 Securities Class Action Deadline

(NASDAQ:SNPS), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal

LRN INVESTOR LOSSES: Lose Money on Stride, Inc.? Contact BFA Law before January 12 Securities Class Action Deadline

(NYSE:LRN), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities

KMX INVESTOR LOSSES: Lose Money on CarMax, Inc.? Contact BFA Law before January 2 Securities Class Action Deadline

(NYSE:KMX), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal

JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation

(NYSE:JEF), NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed. If you invested in Jefferies or Point Bonita, you are

Scroll to Top